InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Friday, 09/05/2014 9:54:05 AM

Friday, September 05, 2014 9:54:05 AM

Post# of 346039
Cell Death Signaling in Cancer and the Immune System (S2)
Scientific Organizers: Gustavo Amarante-Mendes, Douglas R. Green and Kim Newton

October 28—November 2, 2014
Casa Grande Hotel, Guaruja, São Paulo, Brazil


-------------------------------------------------------------

have some fall clean ups to get to, so I just am posting what stood out to me initially. Will have to go thru all the affiliations with a fine tooth comb later ... but Japan seems to like PS Targeting and Takahashi is a very common Japanese name

------------------------------------------------------------

Wed Oct 29 2014

17:00—19:00
Cell Death Signaling II
Registered attendees can view abstracts starting on 09/28/2014

Beth Levine, University of Texas Southwestern Medical Center, USA
Autophagic Cell Death

Peter Vandenabeele, VIB, Ghent University, Belgium
Necroptosis versus Apoptosis


Sat Nov 1

* Peter Vandenabeele, VIB, Ghent University, Belgium

Shigekazu Nagata, Kyoto University, Japan
Exposure of phosphatidylserine during apoptosis


Closing Remarks:

* Gustavo P. Amarante-Mendes, Universidade de São Paulo, Brazil

*Session Chair †Speaker invited, not yet responded. (this looks like they invited "another" speaker as well ?? and not yet responded ?? if so... wonder who...)

Keystone Symposia thanks our Sponsors for generously supporting this meeting:

AbbVie Inc.
Genentech, Inc.
H3 Biomedicine Inc.
National Council for Scientific and Technological Development (CNPq) - Brazil

http://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1321



....... we can't forget Beth Levine with certain ties to NDSU, just pointing it out since NDSU/Fargo had much to do with our little bump in the road

S Sinha1 and B Levine2,3,4

1Department of Chemistry, Biochemistry and Molecular Biology, North Dakota State University, Fargo,ND, USA

2Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA

3Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA

4Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA

S Sinha: ude.usdn@ahnis.atignas; B Levine: ude.nretsewhtuoSTU@eniveL.hteB
Correspondence: Dr S Sinha, Department of Chemistry, Biochemistry and Molecular Biology, North Dakota State University, Fargo, ND, USA. B Levine, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731580/#!po=68.3333




"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News